One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2014.32.15_suppl.9002
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2014 |
 Citations: 74 |
Affiliation: Dana-Farber Cancer Institute, Yale Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Bristol-Myers Squibb (United States), Beth Israel Deaconess Medical Center, University of Michigan–Ann Arbor, Christ Hospital, Vanderbilt University, Carolina BioOncology Institute, Massachusetts General Hospital, Vanderbilt University Medical Center9002 Background: We have shown that nivolumab, a fully human IgG4 PD-1 immune-checkpoint inhibitor antibody, is tolerable and active in pts with advanced solid tumors in a large phase I trial (Topa...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
